- Research team
- Our research programme
- Our research in the media
- Frequently asked questions (FAQ)
- Contact us
- Seminar series
- Join the team - opportunities and vacancies
Gene and Cell Therapy Group
Developing gene and cell therapy for sight loss by translating basic research into new treatments
Transplantation of photoreceptors from retina grown ‘in a dish’
We have carried out the first successful transplant of light-sensitive photoreceptor cells taken from a synthetic retina, grown ‘in a dish’ from embryonic stem cells.
When transplanted into night-blind mice these cells appeared to develop normally, integrating into the existing retina and forming the nerve connections needed to transmit visual information to the brain.
Our latest blog posts
We are currently conducting two ground-breaking clinical trials:
The world's first gene therapy trial in the eye, testing the safety and efficacy of delivering the RPE65 gene to patients with Leber congenital amaurosis (LCA).
Europe's first trial testing the safety of transplanting stem cell-derived retinal cells into the eyes of patients with Stargardt disease
EyeTherapy information hub
Page last modified on 23 jul 13 14:28